Colgate-Palmolive (NYSE:CL) Given Consensus Recommendation of “Hold” by Analysts

Colgate-Palmolive (NYSE:CL) has been assigned a consensus recommendation of “Hold” from the twenty-one brokerages that are currently covering the company, Marketbeat reports. One analyst has rated the stock with a sell recommendation, nine have issued a hold recommendation and eleven have given a buy recommendation to the company. The average 12 month target price among brokerages that have updated their coverage on the stock in the last year is $101.61.

Several equities research analysts recently weighed in on the company. Royal Bank of Canada restated a “sector perform” rating and set a $101.00 target price on shares of Colgate-Palmolive in a report on Wednesday, January 29th. JPMorgan Chase & Co. lowered their price target on Colgate-Palmolive from $103.00 to $97.00 and set an “overweight” rating for the company in a research report on Monday, February 3rd. Piper Sandler lowered their price target on Colgate-Palmolive from $121.00 to $112.00 and set an “overweight” rating for the company in a research report on Monday, January 6th. Wells Fargo & Company lowered their price target on Colgate-Palmolive from $92.00 to $83.00 and set an “underweight” rating for the company in a research report on Tuesday, January 7th. Finally, Stifel Nicolaus lowered their price target on Colgate-Palmolive from $95.00 to $93.00 and set a “hold” rating for the company in a research report on Monday, February 3rd.

Colgate-Palmolive Trading Up 3.8 %

Shares of CL stock opened at $96.84 on Monday. The stock has a market capitalization of $78.59 billion, a PE ratio of 27.51, a P/E/G ratio of 4.20 and a beta of 0.40. Colgate-Palmolive has a 1-year low of $85.32 and a 1-year high of $109.30. The business has a 50-day moving average of $88.84 and a 200 day moving average of $95.11. The company has a debt-to-equity ratio of 13.40, a current ratio of 0.92 and a quick ratio of 0.58.

Colgate-Palmolive (NYSE:CL) last issued its earnings results on Friday, January 31st. The company reported $0.91 earnings per share for the quarter, beating the consensus estimate of $0.90 by $0.01. Colgate-Palmolive had a return on equity of 477.77% and a net margin of 14.38%. During the same quarter in the previous year, the firm posted $0.87 earnings per share. As a group, sell-side analysts anticipate that Colgate-Palmolive will post 3.75 earnings per share for the current year.

Colgate-Palmolive Dividend Announcement

The business also recently disclosed a quarterly dividend, which was paid on Friday, February 14th. Investors of record on Tuesday, January 21st were given a dividend of $0.50 per share. This represents a $2.00 dividend on an annualized basis and a yield of 2.07%. The ex-dividend date was Tuesday, January 21st. Colgate-Palmolive’s dividend payout ratio (DPR) is presently 56.82%.

Institutional Inflows and Outflows

A number of institutional investors and hedge funds have recently added to or reduced their stakes in CL. Swedbank AB boosted its stake in Colgate-Palmolive by 1.4% during the 3rd quarter. Swedbank AB now owns 2,950,059 shares of the company’s stock valued at $306,246,000 after purchasing an additional 40,324 shares during the last quarter. Stephens Inc. AR boosted its stake in Colgate-Palmolive by 2.1% during the 3rd quarter. Stephens Inc. AR now owns 11,951 shares of the company’s stock valued at $1,241,000 after purchasing an additional 251 shares during the last quarter. Creative Financial Designs Inc. ADV boosted its stake in Colgate-Palmolive by 142.1% during the 3rd quarter. Creative Financial Designs Inc. ADV now owns 869 shares of the company’s stock valued at $90,000 after purchasing an additional 510 shares during the last quarter. Gladstone Institutional Advisory LLC boosted its stake in Colgate-Palmolive by 10.3% during the 3rd quarter. Gladstone Institutional Advisory LLC now owns 6,758 shares of the company’s stock valued at $702,000 after purchasing an additional 631 shares during the last quarter. Finally, Americana Partners LLC purchased a new stake in Colgate-Palmolive during the 3rd quarter valued at $356,000. Institutional investors own 80.41% of the company’s stock.

Colgate-Palmolive Company Profile

Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.